Saturday, November 14, 2020

Hospitalizations

 From Liberation: the three waves of Covid-19 hospitalizations

in the US:



Friday, November 13, 2020

Jungle Time

Been working through the lecture on Breakout, as well

as checking out what the other games in the course are.


Got engrossed in this lovely match3 game. Easy and fun;

very rewarding experience:


https://www.match3games.com/game/Jungle+Match


                                         *     *     *

I don't really pronounce myself on the US system of government,

because I have never been taught it's history. I would say, however,

that terming it 'archaic' is an abuse of language. It is complex, and

steeped in the conditions of its elaboration.


https://www.history.com/news/electoral-college-founding-fathers-constitutional-convention

Thursday, November 12, 2020

RussianD

source: L'Obs (Nouvel Observateur) with AFP; posted on November 12, 2020 

translation: GoogleTranslate/doxa-louise

Russia considers the US electoral system one of "the most archaic" in the world

For Moscow, the American system of indirect universal suffrage “considerably distorts the will of the people”.

If the Kremlin has been silent following Joe Biden's victory, it has been more vocal in criticizing American suffrage. The head of Russian diplomacy on Thursday, November 12, described the American electoral system as one of the most "archaic" in the world, after the victory of Joe Biden disputed by Donald Trump .

"They have arguably the most archaic electoral system existing among the few most important countries in the world," Sergei Lavrov said at a press conference.

A "tradition which distorts the will of the people"

The Russian Foreign Minister criticized in particular the indirect nature of the election of the president, who is elected by an elecoral College appointed by universal suffrage.

Developed in the XVIII th  century, this system requires that the winner be not necessarily the one collecting the most votes nationally, but the one who wins the key states with the most electoral votes.

"If  America is prepared to live with this tradition which considerably distorts the will of the people […] that we leave them to it" , blurted Sergey Lavrov.

Moscow did not congratulate Joe Biden

Like Russian President Vladimir Putin, Sergei Lavrov has indicated that Moscow will congratulate the winner of the election only after the publication of the official results. "Congratulations are sent before publication of the results when there is no dispute," Sergey Lavrov stressed. Unlike most countries in the world, China and Russia did not congratulate Joe Biden.

Donald Trump refused to recognize the latter's victory, announced on Saturday, November 7, denouncing, without providing evidence, fraud in favor of the Democrat, and promising legal actions to come.

The head of the Russian electoral commission estimated Monday, November 9 that the postal vote in the United States left "huge spaces" for possible fraud, echoing the rhetoric of Donald Trump's team.


Tuesday, November 10, 2020

Decoupling

 Robert Nystrom might be the Gwyneth Paltrow of

programming, but what he says is marvellously true. The

brain pain involved in programming is very real.

Long term solutions might be a little less idiosyncratic

because machines should eventually program themselves.

Meanwhile, I'm still on this Games course and enjoying it

once I start to understand things...


from: Game Programming Patterns, 2014.

Cakes

 his YouTube site is a true treasure trove of easy dessert recipes.


I have been trying out yogurt cakes, below:

The first is a cake using corn starch instead of flour. The

flan-like texture was predictable. Very tasty.

(The 9% fat coconut yogurt didn't hurt).



The second tastes absolutely wonderful: I made it

with pecans on top, but I eat it with grapes. (The

yogurt I used was 2% plain Scandinavian yogurt).


Monday, November 9, 2020

Certified

  For those wondering how an American Presidential election 

is actually certified:

https://www.snopes.com/news/2020/09/15/who-formally-declares-the-winner-of-the-u-s-presidential-election/


PfizerV

 source: Der Spiegel November 9th, 2020, 12:59 p.m.

Translation: GoogleTranslate/doxa-louise

Fight against the coronavirus

Mainz vaccine manufacturer gives hope for 90 percent protection

The company Biontech has presented the first results from its phase III study: These look very promising. Approval should be applied for next week.

For the first time, there are interim results from the study phase that is decisive for approval for a corona vaccine that is relevant for Europe. As the Mainz-based pharmaceutical company Biontech announced on Monday , according to this data, its vaccination offers more than 90 percent protection against the disease Covid-19. It also said that Biontech and the pharmaceutical giant Pfizer are expected to apply for approval from the US FDA from next week.

The vaccine BNT162b2 had been developed by Biontech in the "Lightspeed" project since mid-January. The phase III study, which is crucial for approval, began in various countries at the end of July. More than 43,500 people have now received at least one of the two vaccinations, which are given every three weeks. According to the manufacturer, vaccination protection is achieved one week after the second injection.

In the study, a total of 94 cases of the disease were confirmed by Sunday. According to the information, the preliminary results will only be finally evaluated when a total of 164 cases have been reached. In addition, it will be checked to what extent the vaccination not only protects against Covid-19, but also against severe courses of the disease. Overall, both the protective effect and any side effects should be observed over a period of two years.

Data should be discussed worldwide

The first interim analysis is preliminary effectiveness data, so the vaccination effectiveness can still change after a longer observation period of the test persons. The Data Monitoring Committee (DMC) also reported "no serious safety concerns" and recommended that the study continue as planned with the collection of additional safety and effectiveness data. In the meantime, the data will be discussed with other regulatory authorities around the world, including the US FDA and the European Ema. A scientific publication is apparently in preparation.

"These are great and promising data," said Gerd Fätkenheuer, head of infectious diseases, Clinic I for Internal Medicine at the University Clinic in Cologne. "It is unbelievable that in such a short period of time this progress with vaccine development and clinical testing could be achieved within a few months." The results so far on effectiveness and safety are excellent.

No primary data yet

The head of Infectious Diseases at the University Medical Center Hamburg-Eppendorf (UKE), Marylyn Addo, who is herself leading a vaccine study, said: "These are interesting first signals, which are only given in the press release." Primary data are not yet available and a peer-reviewed publication is still pending. "We have to wait for the exact dates to make a final assessment. At the moment there are still few details about the exact dates, for example with regard to different age groups and in which groups the 94 cases occurred."

An accelerated approval process applies to the corona vaccine due to its particular urgency. Pharmaceutical manufacturers can submit individual parts on the quality, safety and effectiveness of a preparation to the European Medicines Agency Ema even before the complete application for approval. In addition to Biontech, the British-Swedish company Astrazeneca started such a rolling review process for its vaccine candidate some time ago. Astrazeneca has not yet released any Phase III data. Nothing can be said about the schedule, a spokeswoman said on Monday.

The Biontech preparation is a so-called RNA vaccine. It contains genetic information about the pathogen, from which the body produces a virus protein - in this case the surface protein that the virus uses to penetrate cells. The aim of vaccination is to stimulate the body to produce antibodies against this protein in order to intercept the viruses before they enter the cells and multiply.

Biontech and Pfizer expect to be able to provide up to 50 million vaccine doses worldwide this year, and next year they expect up to 1.3 billion doses.

Countries like Russia, China and recently Bahrain have released vaccines with restrictions and are already vaccinating parts of the population with them. But how well these vaccinations actually protect and what side effects they can have is currently largely open.

                                                        *     *     *